Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 246-073-4 | CAS number: 24199-46-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 6-methylhept-5-en-2-one
- EC Number:
- 203-816-7
- EC Name:
- 6-methylhept-5-en-2-one
- Cas Number:
- 110-93-0
- IUPAC Name:
- 6-methylhept-5-en-2-one
- Details on test material:
- - Name of test material (as cited in study report): 6-Methylhept-5-en-2-one (Methylheptenon)
- Test substance No.: 00/0874-1
- Physical state: colorless liquid
- Analytical purity: 99.1%
- Purity test date: December 28, 2000
- Lot/batch No.: continuous production
- Storage condition of test material: refrigerator (protected from light, N2 conditions)
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH
- Age at study initiation: 5 - 8 weeks according to the information from the breeder
- Weight at study initiation: ca. 28 g
- Identification: cage cards
- Housing: individually, Makrolon cages, type MI,
- Diet (e.g. ad libitum): ad libitum, Standardized pelleted feed (Kliba Haltungsdiät, Provimi Kliba SA, Kaiseraugst, Switzerland)
- Water (e.g. ad libitum): ad libitum drinking water from bottles
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12
ANALYISIS OF FEED, WATER AND BEDDING
- The feed used in the study was assayed for chemical and microbial contaminants.
- The drinking water is regularly assayed for chemical contaminants both by the municipal authorities of Frankenthal and the Department of Water Chemnistry and the Technical Services of BASF Aktiengesellschaft as well as for microorganisms by a contract laboratory.
- The bedding is regularly assayed for contaminants (chlorinated hydrocarbons and heavy metals).
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: olive oil
- Justification for choice of solvent/vehicle: Due to the limited solubility of the test substance in water, olive oil Ph.Eur./DAB was selected as the vehicle, which had been demonstrated to be suitable in the in vivo micronucleus test and for which historical data are available
- Concentration of test material in vehicle: 2, 4, 8 g/100 ml
- Amount of vehicle (if gavage or dermal): 10 ml/kg bw
- Purity: type Ph.Eur./DAB - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
All test substance formulations were prepared immediately before administration.
The amount of substance or volume to be administered was related to the specific weight of the individual animals on the day of the 1st administration. - Duration of treatment / exposure:
- 2 injections at a 24-hour interval; positive control group was treated only once
- Post exposure period:
- samples of bone marrow were taken 24 hours after the last treatment
Doses / concentrations
- Remarks:
- Doses / Concentrations:
200, 400 and 800 mg/kg bw
Basis:
nominal conc.
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - Cyclophosphamide (CPP): 20 mg CPP (Endaxan®, ASTIA MVEDICA, Reg. Nr. E 432-1 )/kg body weight for clastogenic effects
- Vincristine Sulphate (VCR): 0,15 mg VCR (SIGMA - V 8879)/kg body weight for aneugenic effects
- Route of administration: intraperitoneally
- Doses: both control substances were dissolved in purified water were administered to male animals once each in a volume of 10 mI/kg bw
Examinations
- Tissues and cell types examined:
- - bone marrow: polychromatic and normo chromatic erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
In a pretest for the determination of the acute intraperitoneal toxicity death were observed at a dose of 1,000 mg/kg body weight.
800 mg/kg body weight were survived by all animals but led to evident signs of toxicity such as staggering, abdominal position, squatting posture and the general state of the animals was poor, however, showing no distinct symptomatic differences between the male and female animals.
Thus, only male animals were used for the cytogenetic investigations.
Therefore, a dose of 800 mg/kg body weight was selected as the highest dose in the present cytogenetic study.
400 mg/kg and 200 mg/kg body weight were administered as further doses.
DETAILS OF SLIDE PREPARATION:
The bone marrow was prepared according the method described by Schmid (1976) and Salamone (1980):
- The two femora were prepared by dissection and removing all soft tissues.
- After cutting off the epiphyses, the bone marrow was flushed out of the diaphysis into a centrifuge tube using a cannula filled with fetal calf serum which was at 37°C (about 2 ml/femur).
- The suspension was mixed thoroughly with a pipette, centrifuged at 300 x g for 5 minutes, the supernatant was removed and the precipitate was resuspended in about 50 µl fresh FCS.
- 1 drop of this suspension was dropped onto clean microscopic slides, using a Pasteur pipette.
Smears were prepared using slides with ground edges, the preparations were dried in the air and subsequently stained.
The slides were stained in eosin and methylene blue solution for 5 minutes (May Grünwald solution modified = Wrights solution), rinsed in purified water and then placed in fresh purified water for 2 or 3 minutes.
They were finally stained in 7.5% Giemsa solution for 15 minutes.
After being rinsed twice in purified water and clarified in xylene, the preparations were mounted using Corbit-Balsam.
METHOD OF ANALYSIS:
In general, 2,000 polychromatic erythrocytes (PCEs) from each of the male animals of every test group are evaluated and investigated for micronuclei (MN). The normochromatic erythrocytes (NCEs) which occur are also scored. The following parameters are recorded:
- Number of polychromatic erythrocytes
- Number of polychromatic erythrocytes containing micronuclei
The increase in the number of micronuclei in polychromatic erythrocytes of treated animals as compared with the solvent control group provides an index of a ohromosome-breaking (clastogenic) effect or of a spindle activity of the substance tested.
- Number of normochromatic erythrocytes
- Number of normochromatic erythrocytes containing micronuclei
- Ratio of polychromatic to normochromatic erythrocytes
An alteration of this ratio indicates that the test substance actually reached the target.
Individual animals with pathological bone marrow depression may be identified and excluded from the evaluation.
- Number of small micronuclei (d < D/4) and of large micronuclei (d > D/4) (d = diameter of micronucleus, D =cell diameter)
The size of micronuclei may indicate the possible mode of action of the test substance, i.e. a clastogenic or a spindle poison effect.
Slides were coded before microscopic analysis.
Since the absolute values shown have been rounded off but the calculations were made
using the unedited values, deviations in the given relative values can occur. - Evaluation criteria:
- The test chemical is considered positive in this assay if the following criteria are met:
- A dose-related and significant increase in the number of micronucleated polychromatic erythrocytes was observed.
- The proportion of cells containing micronuclei exceeded both the values of the concurrent negative control range and the negative historical control range.
A test substance is generally be considered negative in this test system if:
- There was no significant increase in the number of micronucleated polychromatic erythrocytes at any dose above concurrent control frequencies.
- The frequencies of cells containing micronuclei were within the historical control range. - Statistics:
- The statistical evaluation was carried out using the program system MUKERN (BASF AG):
The number of micronuclei in polychromatic erythrocytes was analyzed.
A comparison of the dose group with the vehicle control was carried out using the Wilcoxon test for the hypothesis of equal medians.
Here, the relative frequencies of cells with micronuclei of each animal were used.
If the results of this test were significant, labels (* for p:5 0.05, ** for p •5 0.01) were printed with the group means in the tables.
This test was performed one-sided.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 800, 1000 mg/kg bw
- Clinical signs of toxicity in test animals: death were observed at a dose of 1,000 mg/kg body weight. 800 mg/kg body weight were survived by
all animals but led to evident signs of toxicity such as staggering, abdominal position, squatting posture and the general state of the animals was poor, however, showing no distinct symptomatic differences between the male and female animals.
Any other information on results incl. tables
RESULTS OF MAIN STUDY: MORTALITY
No mortality occurred in all groups.
CLINICAL SIGNS
The administration of the test substance at 2 x 800 mg/kg bw
led to evident signs of toxicity in all treated animals
(poor general state, abdominal position, squatting posture,
staggering) which were reversible after 2 days. At the 2
lower doses only minor signs of clincal toxicity were
observed after 1 hour of administration of the test
substance (squatting posture).
EFFECT ON PCE/NCE RATIO
No inhibition of erythropoiesis, determined from the PCE/NCE ratio was detected. The vehicle and the the positive control substances, CPP and VCR, caused no evident signs of toxicity.
Mean number of PCEs and NCEs (Interval: 24 hrs)
PCEs NCEs
vehicle 10,000 2,746
200 mg/kg bw 10,000 2,348
400 mg/kg bw 10,000 2,750
800 mg/kg bw 10,000 2,627
CPP (20 mg/kg bw) 10,000 4,129
VCR (0.15 mg/kg bw) 10,000 4,212
GENOTOXIC EFFECTS
Mean number of PCEs containing MN per 1,000 PCE at 24 hrs:
vehicle: 0.3
200 mg/kg bw: 1.0
400 mg/kg bw: 0.9
800 mg/kg bw: 0.7
CPP (20 mg/kg bw): 16.0 (p < = 0.01)
VCR (0.15 mg/kg bw): 52.9 (p < = 0.01)
STATISTICAL EVALUATION
The administration of the test substance did not lead to any
statistically significant increase in the number of
polychromatic erythrocytes containing either small or large
micronuclei. The rate of micronuclei was nearly the range of
the concurrent negative control in all dose groups and
within the range of the historical control data.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
Under the experimental conditions chosen, the test substance
did not have a chromosome-damaging (clastogenic) effect, and
there were no indications of any impairment of chromosome
distribution in the course of mitosis (aneugenic activity)
in bone marrow cells in vivo.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.